A priori considerations when using laboratory determinations in cost-effectiveness and clinical decision analyses

Area of Science:

• Clinical Chemistry
• Medical Decision Making
• Health Services Research

Background:

• Cost-effectiveness and clinical decision analyses rely on laboratory data.
• Inaccurate laboratory data can compromise the validity of these analyses.
• Existing analyses often overlook potential errors in laboratory data generation and use.

Purpose of the Study:

• To identify and categorize sources of error in the laboratory data process.
• To propose a framework for improving the reliability of laboratory data in decision analyses.
• To enhance the accuracy of clinical and economic evaluations using laboratory results.

Main Methods:

• The study identifies three critical phases in the laboratory data pathway: generation, comparison to normal values, and interpretation.
• Phase I: Assesses methodology quality and laboratory performance for analyte value generation errors.
• Phase II: Examines normal value selection and addresses false positives/negatives.
• Phase III: Investigates errors in the interpretation of laboratory values.

Main Results:

• Errors can occur at multiple stages, from initial data generation to final interpretation.
• Failure to account for errors in analyte value generation impacts analysis.
• Inappropriate normal value selection and interpretation errors lead to flawed conclusions.
• False positives and false negatives are significant issues in Phase II.

Conclusions:

• Explicitly identifying and addressing errors across all three phases is essential.
• Strengthening decision analyses requires a comprehensive understanding of laboratory data error sources.
• Implementing error-aware strategies will improve the reliability of cost-effectiveness and clinical decisions.